The human body is built on peptides. These short chains of amino acids act as the body's internal messengers — telling cells to produce hormones, repair tissue, regulate inflammation, and maintain energy. In medicine, peptide therapy harnesses this natural signaling system to address specific health goals with remarkable precision.
Peptide-based drugs are not new. Over 80 peptide medications are FDA-approved worldwide, and more than 170 are currently in active clinical development. The global peptide drug market exceeded $70 billion in 2019 — more than doubling in just six years — a reflection of how rapidly the science has advanced. From insulin to the GLP-1 medications now reshaping obesity treatment, peptides have earned their place as one of the most clinically significant drug classes in modern medicine.
Below is an overview of the peptide therapies with the strongest clinical foundations, a look at topical peptide applications, and an honest account of the risks — including where the real danger in this space actually lies.
Peptide Therapies with the Strongest Clinical Backing
GLP-1 Medications (Semaglutide, Tirzepatide)
GLP-1 medications are among the most well-studied peptides in existence. They work by mimicking a hormone the gut naturally releases after eating, signaling the brain to reduce appetite, slow digestion, and improve blood sugar regulation. The results go well beyond weight loss — clinical research has documented meaningful cardiovascular protection, kidney benefits, and improvements in metabolic health. For patients managing obesity, type 2 diabetes, or elevated cardiovascular risk, these medications represent one of the most significant therapeutic advances in recent decades.
Sermorelin
Sermorelin is a growth hormone-releasing hormone (GHRH) analogue — meaning it stimulates the pituitary gland to produce and release your own natural growth hormone rather than introducing synthetic hormone directly. As we age, growth hormone production naturally declines. Sermorelin is used to support lean muscle development, improve sleep quality, enhance recovery, and promote fat metabolism. Because it works with the body's existing feedback systems rather than overriding them, it is considered one of the more physiologically sound approaches in the growth hormone-related peptide class.
NAD+
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell and essential to energy production, DNA repair, and metabolic regulation. NAD+ levels decline naturally with age, obesity, and cardiovascular stress. Research published in Circulation identifies disrupted NAD+ metabolism as a contributing factor across a range of cardiovascular conditions, including heart failure, arrhythmia, and diabetic cardiomyopathy. NAD+ therapy is used to support cellular energy, combat the effects of aging at the metabolic level, and promote overall cardiovascular and mitochondrial health.
Glutathione
Glutathione is the body's most abundant natural antioxidant — produced from three amino acids and present in virtually every cell. It plays a central role in neutralizing oxidative stress, supporting immune function, and detoxifying harmful compounds. Clinical research has found that supplementation can meaningfully raise glutathione levels in the blood, enhance natural killer cell activity, and reduce markers of systemic oxidative stress. Individuals with depleted glutathione — common with age, illness, and chronic stress — tend to see the most pronounced effects.
Lipo-B
Lipo-B is a lipotropic injection combining vitamin B12 with methionine, inositol, and choline — a formulation designed to support fat metabolism, liver function, and energy levels. B12 is critical to neurological health, red blood cell production, and the regulation of homocysteine, an amino acid linked to cardiovascular disease when elevated. Research from Harvard Health notes that B12 deficiency is far more common than most people realize, particularly in adults over 50. Lipo-B injections offer a direct delivery method for those who absorb B12 poorly through diet or oral supplements alone.
Topical Peptides: GHK-Cu
A note before diving in: injectable GHK-Cu is not FDA approved and is frequently found circulating through unregulated grey-market channels — the same landscape discussed in the risks section below. The FDA review of injectable GHK-Cu is expected in early 2027. Until that process is complete and a safety and efficacy determination is made, injectable forms should be approached with the same caution as any unapproved compound.
The topical application of GHK-Cu is a different matter entirely. GHK-Cu (copper peptide) is a naturally occurring peptide that stimulates collagen and elastin production in the skin, supports wound healing, and has demonstrated anti-inflammatory properties when applied topically. Studies on similar collagen-stimulating peptides have shown measurable reductions in wrinkle depth and improvements in skin texture with consistent use. In topical form, GHK-Cu has a strong safety profile with no systemic absorption concerns — making it one of the better-characterized peptides in dermatological applications.
Risks Worth Understanding
Peptide therapy has a strong safety profile when medications are sourced and administered correctly. But that qualifier — correctly — matters enormously.
Common Side Effects
Side effects vary by peptide. GLP-1 medications commonly cause nausea and GI discomfort, especially early in treatment. Injectable peptides generally carry the risk of injection-site irritation, headache, and fatigue. Most side effects are manageable with proper dosing and clinical oversight.
The Grey Market Problem
Here is where the real risk lies. The AMA has warned explicitly that a growing number of peptides are being sold through wellness spas, online retailers, and social media channels with no FDA oversight, no verified manufacturing standards, and no clinical accountability. These products are often labeled "for research use only" — a designation that is frequently misused to sell compounds intended for human injection.
The risks are serious: unknown purity, inconsistent dosing, contamination from overseas manufacturing facilities, and the potential for allergic reactions up to and including anaphylaxis. In September 2023, the FDA banned copper peptide injections — not because of the peptide itself, but because of impurities in unregulated products that were triggering immune reactions. The compound was not the problem. The manufacturing was.
Harvard Health notes that many grey-market peptide products have not been vetted by any medical authority, and their health claims have not been evaluated in controlled human trials. Buying and injecting these compounds outside of a clinical setting is a significant and consistently underappreciated risk.
What Safe Looks Like
Safe peptide therapy means medications compounded by an FDA-regulated, state-licensed sterile pharmacy — one that adheres to USP 797 standards for sterile preparations. It means physician oversight, appropriate lab work, and dosing calibrated to the individual. It means a paper trail, a provider who is accountable, and a product whose purity has been verified.
If someone is offering injectable peptides without a prescription, without a licensed provider, or without being able to name the compounding pharmacy and its credentials — that is a red flag. The convenience of bypassing the clinical process is never worth the risk of what goes into a product you cannot verify.
The Right Path Forward
Peptide therapy works. The science is real, the clinical track record for well-studied compounds is strong, and the pipeline of emerging treatments continues to grow. But the difference between a therapeutic outcome and a harmful one often comes down to one thing: where the medication came from and who is overseeing the treatment.
If you're curious about whether peptide therapy is right for you, the right first step is a conversation with a licensed provider who can evaluate your health history and guide you toward what the evidence actually supports — dispensed through a verified sterile compounding pharmacy, and monitored throughout the course of treatment.
